內部控制缺失暨創新能力對資產減損之影響

The Impacts of Internal Control Weaknesses and Innovation Capability on Assets Impairment

本文主要以2005年至2018年的上市櫃公司為研究對象，並探討企業內部控制制度、創新能力與資產減損認列之關聯性。本文以手工蒐集首次上市櫃及現金增資公司出具的公開說明書裡，最近三年度會計師提出之內部控制制度改進建議，作為判斷內部控制缺失數目的依據，並以研究發展支出、專利權數及創新效率三個變數來衡量企業的創新能力。實證結果顯示，內部控制缺失數目愈多的企業，資產減損認列的金額愈高。創新能力與資產減損認列金額呈現負向關係，然而，內部控制缺失緩和了創新能力與資產減損的負向關係，意涵著內部控制品質與創新能力對於企業的資產評價決策，扮演了重要的角色。

 

The purpose of this study is to investigate the associations among internal control weaknesses (hereafter ICWs), innovation capability, and assets impairment recognition for firms publicly listed in Taiwan from 2005 to 2018. The numbers of the ICW data are manually collected from the prospectuses of initial public offering and seasoned equity offering firms (hereafter IPO/SEO). The CPAs were required to set forth their suggestions for the improvement of the internal control system and ICWs in the prospectuses for the last three years. We employed three variables: research and development expenditures (hereafter R&D), patent numbers, and innovation efficiency to proxy for corporate innovation capability. The empirical results show that firms with more ICWs have higher amount of recognized assets impairment loss. There is a negative relationship between innovation capability and the amount of recognized assets impairment loss. However, the negative relationship will be depressed for firms with more ICWs, implying that internal control quality and innovation capability both play an important role in a firm’s assets valuation decisions.